Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP300675.RAr4GRO5i1k4K2x2JX52kV-LBxR1hp77TUT6DgWf1_K9g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP300675.RAr4GRO5i1k4K2x2JX52kV-LBxR1hp77TUT6DgWf1_K9g130_assertion type Assertion NP300675.RAr4GRO5i1k4K2x2JX52kV-LBxR1hp77TUT6DgWf1_K9g130_head.
- NP300675.RAr4GRO5i1k4K2x2JX52kV-LBxR1hp77TUT6DgWf1_K9g130_assertion description "[Although the frequency of mutations in the p16/CDKN2 gene has been detected in approximately 30% of non-small cell lung cancer, loss of heterozygosity on 9p has been observed in greater than 70% of non-small cell lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300675.RAr4GRO5i1k4K2x2JX52kV-LBxR1hp77TUT6DgWf1_K9g130_provenance.
- NP300675.RAr4GRO5i1k4K2x2JX52kV-LBxR1hp77TUT6DgWf1_K9g130_assertion evidence source_evidence_literature NP300675.RAr4GRO5i1k4K2x2JX52kV-LBxR1hp77TUT6DgWf1_K9g130_provenance.
- NP300675.RAr4GRO5i1k4K2x2JX52kV-LBxR1hp77TUT6DgWf1_K9g130_assertion SIO_000772 8988029 NP300675.RAr4GRO5i1k4K2x2JX52kV-LBxR1hp77TUT6DgWf1_K9g130_provenance.
- NP300675.RAr4GRO5i1k4K2x2JX52kV-LBxR1hp77TUT6DgWf1_K9g130_assertion wasDerivedFrom befree-20150227 NP300675.RAr4GRO5i1k4K2x2JX52kV-LBxR1hp77TUT6DgWf1_K9g130_provenance.
- NP300675.RAr4GRO5i1k4K2x2JX52kV-LBxR1hp77TUT6DgWf1_K9g130_assertion wasGeneratedBy ECO_0000203 NP300675.RAr4GRO5i1k4K2x2JX52kV-LBxR1hp77TUT6DgWf1_K9g130_provenance.